How Edgewise, Up 55%, Is Hoping To Edge Out Bristol, Cytokinetics In Heart Disease
Investor's Business DailyEdgewise Therapeutics stock skyrocketed on Thursday after a single dose of its drug improved heart function in cardiomyopathy patients.
The post How Edgewise, Up 55%, Is Hoping To Edge Out Bristol, Cytokinetics In Heart Disease appeared first on Invest…